Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME0566) | |||||
---|---|---|---|---|---|
DME Name | Prostaglandin dehydrogenase 1 (HPGD), Homo sapiens | DME Info | |||
UniProt ID | |||||
EC Number | EC: 1.1.1.141 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
ICD Disease Classification 02 Neoplasms | |||||
ICD-11: 2A00 Brain cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Melanocytoma | Moderate hypomethylation | |||
Interaction Name | DNMT-HPGD interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Moderate hypomethylation p-value: 4.87E-03; delta-beta: -2.82E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the HPGD gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Prostaglandin dehydrogenase 1. As a result, the interaction between DNMT and HPGD can moderatly affect the drug-metabolizing process of Prostaglandin dehydrogenase 1. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
ICD-11: 2B62 Tongue squamous cell carcinoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Non-coding RNA regulation | |||||
hsa-miR-21-3p | Tongue squamous cell carcinoma | Suppression | |||
miRBase ID | |||||
Interaction Name | hsa-miR-21-3p--HPGD regulation | [1] | |||
Studied Cell Lines | UM1, UM2, SCC9 and Tca8113 cell lines | ||||
Description | hsa-miR-21-3p is reported to suppress HPGD mRNA translation by binding to the 3' untranslated region (3'UTR) of HPGD mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Prostaglandin dehydrogenase 1. | ||||
ICD-11: 2C12 Liver cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Non-coding RNA regulation | |||||
hsa-miR-21-5p | Liver cancer | Suppression | |||
miRBase ID | |||||
Interaction Name | hsa-miR-21-5p--HPGD regulation | [2] | |||
Studied Cell Lines | CCLP1, SG231, HuCCT1 and TFK1 cell lines | ||||
Description | hsa-miR-21-5p is reported to suppress HPGD mRNA translation by binding to the 3' untranslated region (3'UTR) of HPGD mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Prostaglandin dehydrogenase 1. | ||||
ICD-11: 2C25 Lung cancer | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
Transcription-factor regulation | |||||
Zinc finger SNAI2 (SNAI2) | Lung cancer | Repression | |||
Uniprot ID | |||||
Interaction Name | SNAI2-HPGD interaction | [3] | |||
Studied Cell Lines | NSCLC cell line | ||||
Ensembl ID | |||||
Description | Zinc finger SNAI2 (SNAI2) is reported to repress the transcription of HPGD gene, which leads to a decreased expression of the drug-metabolizing enzyme Prostaglandin dehydrogenase 1. As a result, the interaction between SNAI2 and HPGD can repress the drug-metabolizing process of Prostaglandin dehydrogenase 1. | ||||
ICD-11: 2E06 Prostate cancer metastasis | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
DNA methylation | |||||
DNA methyltransferase (DNMT) | Prostate cancer metastasis | Significant hypomethylation | |||
Interaction Name | DNMT-HPGD interaction | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 9.20E-07; delta-beta: -4.15E-01 | ||||
Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the HPGD gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Prostaglandin dehydrogenase 1. As a result, the interaction between DNMT and HPGD can significantly affect the drug-metabolizing process of Prostaglandin dehydrogenase 1. | ||||
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
Violin Diagram of DME Disease-specific Methylation Level | Click to View the Clearer Original Diagram | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.